Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea

Clinical and Diagnostic Laboratory Immunology

Volumn 8, Issue 1, 2001, Pages 14-20

  Park, J W ^a   Moon, S H ^a   Yeom, J S ^a   Lim, K J ^a   Sohn, M J ^a   Jung, W C ^a   Cho, Y J ^a   Jeon, K W ^a   Ju, W ^a   Ki, C S ^a   Oh, M D ^a   Choe, K ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MEMBRANE PROTEIN;

ANTIBODY RESPONSE; ARTICLE; CARBOXY TERMINAL SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOBLOTTING; KOREA; MALARIA; MEROZOITE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELAPSE;

ADULT; ANIMALS; ANTIBODIES, PROTOZOAN; HUMANS; KOREA; MALARIA, VIVAX; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM VIVAX; POLYMERASE CHAIN REACTION; RECOMBINANT FUSION PROTEINS;

EID: 0035166884     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.8.1.14-20.2001     Document Type: Article

References (31)

1. A single fragment of a malaria merozoite surface protein remains on the parasite during red blood cell invasion and is the target of invasion-inhibiting antibodies
2. Proteolyric processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains
3. A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii
4. Occurrence of tertian malaria in a male patient who has never been abroad
5. A carboxyl-terminal fragment of Plasmodium falciparum gp 195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth
6. Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1
7. Two vivax malaria cases detected in Korea
8. Human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax
9. Reemergence of Plasmodium vivax malaria in the Republic of Korea
10. Antibody response to the circumsporozoite protein of Plasmodium vivax in naturally infected humans
11. Plasmodium vivax: Merozoites, invasion of reticulocytes, and considerations for malaria vaccine development
12. Overview of N- and O-linked oligosaccharide structures found in various yeast species
13. Structure and expression of the gene for Pv200, a major blood-stage surface antigen of Plasmodium vivax
14. Malaria in Korean veterans
15. Transformation of yeast
16. The precursor to major merozoite surface antigens: Structure and role in immunity
17. Low immunogenicity of a Plasmodium vivax circumsporozoite protein epitope bound by a protective monoclonal antibody
18. 19) variants secreted from Saccharomyces cerevistae
19. 19, secreted from Saccharomyces cerevisiae
20. Repetitive proteins and genes of malaria
21. Characterization of naturally acquired human IgG responses against the N-terminal region of the merozoite surface protein 1 of Plasmodium vivax
22. Long-lasting protective immunity against rodent malaria parasite infection at the blood stage by recombinant BCG secreting merozoite surface protein-1
23. Longitudinal study of naturally acquired humoral immune responses against the merozoite surface protein 1 of Plasmodium vivax in patients from Rondonia, Brazil
24. Malaria in Korea
25. Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites
26. A strain of Plasmodium vivax characterized by prolonged incubation: The effect of numbers of sporozoites on the length of the prepatent period
27. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction
28. Sporozoites, antibodies, and malaria in children in a rural area of The Gambia
29. Longevity of naturally acquired antibody responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1
30. Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria
31. Prevalence of antibody to heterologous circumsporozoite protein of Plasmodium vivax in Thailand